Marc Wilson Crinetics Pharmaceuticals, Inc. (CRNX) insider trading activity
Marc Wilson is CFO of Crinetics Pharmaceuticals, Inc.. Currently has a direct ownership of 110,630 shares of CRNX, which is worth approximately $4.96 Million. The most recent transaction as insider was on Mar 19, 2024, when has been sold 6,942 shares (Common Stock) at a price of $42.91 per share, resulting in proceeds of $297,881. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
111K
0%
3M change
16.26%
12M change
Total Value Held
$4.96 Million
Marc Wilson Transaction History
MW
Marc Wilson
CFO
San Diego, CA